We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma

    Little is known on the relationship between the expression of pyroptosis related genes (PRGs) and prognosis of hepatocellular carcinoma (HCC). In...

    Guoxu Fang, Qinghua Zhang, ... **gfeng Liu in BMC Cancer
    Article Open access 20 September 2022
  2. Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma

    Background

    Immunoblockade therapy based on the PD-1 checkpoint has greatly improved the survival rate of patients with skin cutaneous melanoma (SKCM)....

    Shaolong Leng, Gang Nie, ... Linyu Zhu in Cancer Cell International
    Article Open access 26 September 2023
  3. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation

    Background

    Hepatocellular carcinoma (HCC) is one of the most lethal cancers, with a poor prognosis. Prognostic biomarkers for HCC patients are...

    Renguo Guan, **gwen Zou, ... Rong** Guo in BMC Cancer
    Article Open access 30 July 2022
  4. Prognosis and Immune Landscapes in Glioblastoma Based on Gene-Signature Related to Reactive-Oxygen-Species

    Glioblastoma (GBM) is the most malignant and aggressive primary brain tumor and is highly resistant to current therapeutic strategies. Previous...

    Prashant Kaushal, Junle Zhu, ... Chun Luo in NeuroMolecular Medicine
    Article 02 July 2022
  5. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma

    Background

    Thyroid carcinoma (THCA) is the most common endocrine-related malignant tumor. Despite the good prognosis, some THCA patients may...

    Yuan Qin, Dai Zhang, ... Juliang Zhang in Cancer Cell International
    Article Open access 29 September 2022
  6. Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer

    Background

    To investigate the association between computed tomography (CT)-detected extramural venous invasion (EMVI)-related genes and immunotherapy...

    Hao Yang, **nyi Gou, ... ** Cheng in Journal of Translational Medicine
    Article Open access 05 January 2023
  7. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma

    Background

    Lung adenocarcinoma (LUAD) is the most common histological type of lung cancer with lower survival rates. Recent advancements in targeted...

    Shengqiang Mao, Yilong Wang, ... Li Zhang in Cellular Oncology
    Article 15 April 2024
  8. Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma

    Background

    Liver specific genes (LSGs) are crucial for hepatocyte differentiation and maintaining normal liver function. A deep understanding of LSGs...

    **uzhi Zhang, Zhefeng **ao, ... **aoli liu in Cancer Cell International
    Article Open access 19 February 2024
  9. Exploration of a hypoxia-immune-related microenvironment gene signature and prediction model for hepatitis C-induced early-stage fibrosis

    Background

    Liver fibrosis contributes to significant morbidity and mortality in Western nations, primarily attributed to chronic hepatitis C virus...

    Chuwen Chen, Haozheng Cai, ... Tianfu Wen in Journal of Translational Medicine
    Article Open access 29 January 2024
  10. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer

    Background

    An imbalance of intracellular iron metabolism can lead to the occurrence of ferroptosis. Ferroptosis can be a factor in the remodeling of...

    **ao-Fen Li, Wen-Fen Fu, ... Chuan-Gui Song in BMC Cancer
    Article Open access 07 June 2022
  11. Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma

    PANoptosis is a specific type of inflammatory programmed cell death (PCD) modality that can be involved in three key modes of cellular programmed...

    Yan Xu, **gqi Hua, ... Jianjun **e in BMC Cancer
    Article Open access 04 March 2024
  12. The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

    Background

    Bladder cancer (BCa) shows its potential immunogenity in current immune-checkpoint inhibitor related immunotherapies. However, its...

    Liren Jiang, Siteng Chen, ... Feng Gao in BMC Cancer
    Article Open access 20 June 2022
  13. Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma

    Glioblastoma (GBM) is the most invasive type of glioma and is difficult to treat. Diverse programmed cell death (PCD) patterns have a significant...

    Jian Li, Zhaoming Song, ... Zhong Wang in Journal of Molecular Neuroscience
    Article Open access 12 January 2024
  14. The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer

    Background

    Findings from numerous studies have revealed that ferroptosis is closely related to tumorigenesis and immune cell infiltration. Long...

    Chunhui Liu, Yue Gao, ... Ming Chen in BMC Cancer
    Article Open access 18 July 2022
  15. A m6A methyltransferase-mediated immune signature determines prognosis, immune landscape and immunotherapy efficacy in patients with lung adenocarcinoma

    Background

    As the most abundant modification in mRNA, the N 6 -methyladenosine (m 6 A) RNA modification is involved in the occurrence and development of...

    Mengyuan Lei, Chenghan Luo, ... Min Zhao in Cellular Oncology
    Article 15 August 2022
  16. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma

    Background

    Glioblastoma (GBM) is considered the most malignant and devastating intracranial tumor without effective treatment. Autophagy, apoptosis,...

    Ying Bi, Zeng-Hong Wu, Fei Cao in BMC Cancer
    Article Open access 03 March 2022
  17. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer

    Background

    N6-methyladenosine (m6A) related long noncoding RNAs (lncRNAs) may have prognostic value in bladder cancer for their key role in...

    Zi-Hao Feng, Yan-** Liang, ... Zhen-Hua Chen in Journal of Translational Medicine
    Article Open access 29 October 2022
  18. An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer

    Background

    Patients with small-cell lung cancer (SCLC) are burdened by limited treatment options and the disease’s dismal prognosis. Long non-coding...

    Zhihui Zhang, Yuejun Luo, ... Jie He in Cancer Cell International
    Article Open access 20 December 2021
  19. Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer

    Necroptosis has been shown to play an important role in the development of tumors. However, the characteristics of the necroptosis-related subtypes...

    Fan Zhang, Chenxue Qi, ... Hong** **a in Apoptosis
    Article 03 October 2023
  20. A hypoxia–glycolysis–lactate-related gene signature for prognosis prediction in hepatocellular carcinoma

    Background

    Liver cancer ranks sixth in incidence and third in mortality globally and hepatocellular carcinoma (HCC) accounts for 90% of it. Hypoxia,...

    **aodan Qin, Huiling Sun, ... Shukui Wang in BMC Medical Genomics
    Article Open access 16 April 2024
Did you find what you were looking for? Share feedback.